1. Home
  2. ANDE vs NBTX Comparison

ANDE vs NBTX Comparison

Compare ANDE & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANDE
  • NBTX
  • Stock Information
  • Founded
  • ANDE 1947
  • NBTX 2003
  • Country
  • ANDE United States
  • NBTX France
  • Employees
  • ANDE N/A
  • NBTX N/A
  • Industry
  • ANDE Farming/Seeds/Milling
  • NBTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANDE Industrials
  • NBTX Health Care
  • Exchange
  • ANDE Nasdaq
  • NBTX Nasdaq
  • Market Cap
  • ANDE 1.6B
  • NBTX 1.3B
  • IPO Year
  • ANDE N/A
  • NBTX 2020
  • Fundamental
  • Price
  • ANDE $46.31
  • NBTX $20.87
  • Analyst Decision
  • ANDE Buy
  • NBTX Strong Buy
  • Analyst Count
  • ANDE 3
  • NBTX 1
  • Target Price
  • ANDE $51.67
  • NBTX $8.00
  • AVG Volume (30 Days)
  • ANDE 295.6K
  • NBTX 140.8K
  • Earning Date
  • ANDE 11-04-2025
  • NBTX 09-30-2025
  • Dividend Yield
  • ANDE 1.68%
  • NBTX N/A
  • EPS Growth
  • ANDE N/A
  • NBTX N/A
  • EPS
  • ANDE 2.35
  • NBTX N/A
  • Revenue
  • ANDE $11,539,093,000.00
  • NBTX $11,930,711.00
  • Revenue This Year
  • ANDE $9.61
  • NBTX N/A
  • Revenue Next Year
  • ANDE $2.89
  • NBTX $114.97
  • P/E Ratio
  • ANDE $19.70
  • NBTX N/A
  • Revenue Growth
  • ANDE N/A
  • NBTX N/A
  • 52 Week Low
  • ANDE $31.03
  • NBTX $2.76
  • 52 Week High
  • ANDE $51.58
  • NBTX $30.35
  • Technical
  • Relative Strength Index (RSI)
  • ANDE 61.37
  • NBTX 52.17
  • Support Level
  • ANDE $46.15
  • NBTX $17.37
  • Resistance Level
  • ANDE $47.49
  • NBTX $28.51
  • Average True Range (ATR)
  • ANDE 1.44
  • NBTX 1.82
  • MACD
  • ANDE -0.03
  • NBTX -1.07
  • Stochastic Oscillator
  • ANDE 72.65
  • NBTX 41.81

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: